Synopsys
$493.38Change from previous close: +0.58%Absolute change: +$2.84
At a glance
- Revenue growth
- +15.12%
- FY to Oct 2025 vs FY to Oct 2024
- Net income growth
- −41.14%
- FY to Oct 2025 vs FY to Oct 2024
- Net margin
- 18.9%
- FY to Oct 2024: 36.9%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Oct 2025 | FY to Oct 2024 | FY to Oct 2023 | FY to Oct 2022 | FY to Oct 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 1,519 | 1,407 | 1,703 | 1,739 | 1,493 |
| Depreciation and amortization | 413 | 190 | 199 | 183 | 154 |
| Capital expenditure | -169 | -140 | -190 | -137 | -93.8 |
| Investing cash flow | -15,881 | 1,223 | -482 | -573 | -549 |
| Financing cash flow | 13,356 | -181 | -1,197 | -1,116 | -749 |
| Share repurchases | -306 | -338 | -1,402 | -1,274 | -892 |
| Debt issued | 14,329 | 0.0 | 0.0 | 0.0 | — |
| Debt repaid | -864 | -2.6 | -2.6 | -76.8 | — |
| Effect of exchange rates | 1.9 | 8.8 | -3.0 | -65.3 | 2.4 |
| Net change in cash | -1,005 | 2,458 | 21.3 | -15.3 | 197 |
| Free cash flow | 1,349 | 1,268 | 1,514 | 1,602 | 1,399 |
| Levered free cash flow | 2,171 | 800 | 1,265 | 1,550 | 1,301 |